Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Miley G. Nikirk
Advertisement
Articles by Miley G. Nikirk
Advertisement
Latest Updated Articles
Combating Advancing Cancers With CAR T-Cell TherapySeptember 8th 2019
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
2
Real-World Semaglutide Use Linked to Lower Liver Stiffness, With Benefits Beyond Weight Loss
3
After 2 CRLs, FDA Approves Vusolimogene Oderparepvec With Nivolumab for Advanced Melanoma
4
GLP-1s Linked to Fewer Alcohol-Related Hospitalizations
5